Theravance Biopharma, Inc. Business Operations Contracts & Agreements
14 Contracts & Agreements
- Collaboration Agreements (2 contracts)
- Cooperation Agreements (1)
- Development Agreements (3)
- Management Agreements (1)
- Settlement Agreements (2)
- Supply Agreements (4)
- Termination Agreements (1)
- Cooperation Agreement, dated as of December 21, 2023, by and among Theravance Biopharma, Inc., a Cayman Islands exempted company, Irenic Capital Management LP, a Delaware limited... (Filed With SEC on December 21, 2023)
- Settlement Agreement and Release of Claims by and between Andrew Hindman and Theravance Biopharma US, Inc., dated January 10, 2023 (Filed With SEC on March 1, 2023)
- Settlement Agreement by and between Ann Brady and Theravance Biopharma Ireland Limited, dated November 2, 2021 (Filed With SEC on February 28, 2022)
- License and Collaboration Agreement by and between Theravance Biopharma Ireland Limited and Janssen Biotech, Inc. dated as of February 5, 2018 (Filed With SEC on February 26, 2021)
- Development and Commercialization Agreement by and between Theravance Biopharma R&D, Inc. and Mylan Ireland Limited, dated January 30, 2015 (Filed With SEC on February 26, 2021)
- Cooperation Agreement among Theravance Biopharma, Inc., GSK Finance (No.3) plc and GlaxoSmithKline plc dated June 22, 2020 (Filed With SEC on June 25, 2020)
- Amendment No. 1 to the Development and Commercialization Agreement by and between Theravance Biopharma Ireland Limited and Mylan Ireland Limited, dated June 12, 2019 (Filed With SEC on August 5, 2019)
- Amendment and Termination of Rights Agreement, dated as of May 1, 2018, between the Company and Computershare Inc (Filed With SEC on May 1, 2018)
- FOURTH AMENDMENT TO TECHNOLOGY TRANSFER AND SUPPLY AGREEMENT between PFIZER, INC. and THERAVANCE BIOPHARMA IRELAND LIMITED (Filed With SEC on November 9, 2016)
- THIRD AMENDMENT TO TECHNOLOGY TRANSFER AND SUPPLY AGREEMENT between HOSPIRA WORLDWIDE, INC. and THERAVANCE BIOPHARMA IRELAND LIMITED (Filed With SEC on November 9, 2016)
- SECOND AMENDMENT TO TECHNOLOGY TRANSFER AND SUPPLY AGREEMENT between BETWEEN HOSPIRA WORLDWIDE, INC. and THERAVANCE BIOPHARMA ANTIBIOTICS, INC. (Filed With SEC on November 9, 2016)
- FIRST AMENDMENT TO TECHNOLOGY TRANSFER AND SUPPLY AGREEMENT BETWEEN HOSPIRA WORLDWIDE, INC. and THERAVANCE, INC. (Filed With SEC on November 9, 2016)
- LICENSE AND COLLABORATION AGREEMENT BY AND BETWEEN THERAVANCE BIOPHARMA IRELAND LIMITED AND MILLENNIUM PHARMACEUTICALS, INC. DATED JUNE 8, 2016 (Filed With SEC on August 9, 2016)
- DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on April 24, 2015)